Pegylated recombinant human erythropoietin (Shenzen Saibaoer Biotech)
聚乙二醇重组人促红素（深圳赛保尔生物）
Report date: 2022/01/14 13:23:58
Base Information
Drug NamePegylated recombinant human erythropoietin (Shenzen Saibaoer Biotech)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesShenzhen Sciprogen Bio-Pharmaceutical Co Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesShenzhen Sciprogen Bio-Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A